MAPK1 and hereditary clear cell renal cell carcinoma: TOPK is also a direct downstream substrate of ERK2, which is activated by direct phosphorylation of TOPK at S32, and after activation, TOPK plays an important role in sorafenib resistance in renal cell carcinoma (RCC) [33].